Observational studyBMC nephrology2021

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre.

Maximilien Grall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.